This CTD dossier owner and manufacturer specializes in manufacturing sterile dry powder injections, including beta-lactam, cephalosporins, carbapenems, macrolide antibiotics, PPI inhibitors, and corticosteroids. They also produce liquid injections, dry syrups, oral liquids and suspensions, topical creams and gels, and tablets. The company operates as a 100% export-oriented unit with a focus on emerging markets in Asia, Latin America, Central America, the Caribbean Islands, and Africa. They adhere to international good manufacturing practices (GMP) certifications and offer both branded generic and generic products at affordable prices. Their key therapy areas include invasive surgeries, respiratory diseases, and gastroenterology. The company provides contract manufacturing services for pharmaceutical companies and distributors globally, offering regulatory support for product registration.